Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis E Vaccine Efficacy Trial in Nepal
NCT00287469Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Jul 2001
- Primary completion
- Jan 2004
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of HEV 239 in hepatitis E (HEV), sponsored by U.S. Army Medical Research and Development Command. Started Jul 2001; status: completed.
02
Drugs
HEV 239
03
Conditions
hepatitis E (HEV)
Beyond the preview
Go deeper on NCT00287469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287469.